Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_45232 | 32 | 0.66 | Mlig455_067516 | Neo: - Age: Down-Up-Down |
SLC16A14 | Mlig455_067516 {REF} {Length: 2823} {Pfam: Major Facilitator Superfamily [PF07690.18, score=120.8]; Sugar (and other) transporter [PF00083.26, score=21.6]} {Human: ENSG00000163053, SLC16A14, solute carrier family 16 member 14, [Score=147, Expect=2e-37]} {Mouse: ENSMUSG00000026220, Slc16a14, solute carrier family 16 (monocarboxylic acid transporters), member 14, [Score=146, Expect=4e-37]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=311, Expect=4e-97]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=300, Expect=3e-93]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=199, Expect=8e-56]} {RNA1509_49065} {RNA1310_24115} {RNA815_15685} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.061 | 1.159 | 0.99960 | 1.00000 | |
RegionR2 | 0.984 | 1.159 | 0.61178 | 0.95923 | |
RegionR3 | 1.056 | 1.159 | 0.42486 | 0.94669 | |
RegionR4 | 3.428 | 1.159 | 0.05799 | 0.21301 | |
RegionR5 | -2.048 | 1.159 | 0.98921 | 1.00000 | |
RegionR6 | -0.127 | 1.159 | 0.83073 | 1.00000 | |
RegionR7 | 0.028 | 1.159 | 0.83894 | 1.00000 | |
RegionR8 | -4.383 | 1.159 | 0.99969 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -1.707 | 1.159 | 0.99997 | 1.00000 | |
RegenerationR2 | -0.487 | 1.159 | 0.57980 | 0.90693 | |
RegenerationR3 | -2.351 | 1.159 | 0.04562 | 0.37260 | |
RegenerationR4 | -4.76 | 1.159 | 0.00185 | 0.05359 | |
RegenerationR5 | 1.53 | 1.159 | 0.27557 | 0.70457 | |
RegenerationR6 | 0.643 | 1.159 | 0.61450 | 0.87685 | |
RegenerationBL | -0.973 | 1.159 | 0.99982 | 1.00000 | |
RegenerationTP | -2.668 | 1.159 | 0.99983 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_45232 | 32 | 0.66 | Mlig455_067516 | Neo: - Age: Down-Up-Down |
SLC16A14 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_067516 {REF} {Length: 2823} {Pfam: Major Facilitator Superfamily [PF07690.18, score=120.8]; Sugar (and other) transporter [PF00083.26, score=21.6]} {Human: ENSG00000163053, SLC16A14, solute carrier family 16 member 14, [Score=147, Expect=2e-37]} {Mouse: ENSMUSG00000026220, Slc16a14, solute carrier family 16 (monocarboxylic acid transporters), member 14, [Score=146, Expect=4e-37]} {Dmel: FBgn0023549, Mct1, Monocarboxylate transporter 1, [Score=311, Expect=4e-97]} {Celegans: WBGene00015676, mct-6, MonoCarboxylate Transporter family, [Score=300, Expect=3e-93]} {Smed: dd_Smed_v6_9402_0_1, dd_Smed_v6_9402_0_1, [Score=199, Expect=8e-56]} {RNA1509_49065} {RNA1310_24115} {RNA815_15685} |
2. | MligTC455_43506 | 73 | 1.53 | Mlig455_006107 | Neo: - |
3.343 | 0.967 | 0.739 | 0.915 | 0.722 | - | - | Mlig455_006107 {REF} {Length: 703} {RNA1509_17222} {RNA1310_44913.1} {RNA815_37256} | |
3. | MligTC455_32149 | 36 | 0.75 | Mlig455_033666 | Neo: - Age: Up-Down-Up |
2.758 | 0.996 | - | 0.924 | - | 0.838 | - | Mlig455_033666 {REF} {Length: 2371} {Pfam: Ribosomal protein S31e [PF17067.7, score=24.1]} {RNA1509_26752} {RNA1310_51800} {RNA815_53946} | |
4. | MligTC455_18746 | 23 | 0.47 | Mlig455_024831 | Neo: - Age: - Region-enriched R4: 8.220/0.00001 Regeneration-depleted R4: -6.352 |
2.663 | 0.982 | - | 0.847 | 0.834 | - | - | Mlig455_024831 {REF} {Length: 1230} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=52.0, Expect=1e-07]} {RNA1509_9302} {RNA1310_672.1} {RNA815_6919} | |
5. | MligTC455_26092 | 67 | 1.39 | Mlig455_048489 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.677 Region-enriched R2: 4.303/0.01110 |
2.633 | 0.997 | - | 0.717 | 0.919 | - | - | Mlig455_048489 {REF} {Length: 2319} {Pfam: Lectin C-type domain [PF00059.23, score=23.3]} {RNA1509_25383} {RNA1310_27113} {RNA815_24719} | |
6. | MligTC455_33633 | 40 | 0.84 | Mlig455_019135 | Neo: - |
P2RX4 | 2.591 | - | - | 0.996 | 0.759 | 0.836 | - | Mlig455_019135 {REF} {Length: 6429} {Pfam: ATP P2X receptor [PF00864.21, score=235.0]} {Human: ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=175, Expect=5e-50]} {Mouse: ENSMUSG00000029470, P2rx4, purinergic receptor P2X, ligand-gated ion channel 4, [Score=166, Expect=4e-47]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=244, Expect=4e-76]} {RNA1509_56886} {RNA1310_29566.2} {RNA815_42779} |
7. | MligTC455_33880 | 65 | 1.35 | Mlig455_057597 | Neo: - Age: - |
GRIN2A | 2.535 | 0.993 | - | 0.727 | 0.815 | - | - | Mlig455_057597 {REF} {Length: 4580} {Pfam: Ligand-gated ion channel [PF00060.28, score=102.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.1]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=74.4]; Receptor family ligand binding region [PF01094.30, score=30.9]} {Human: ENSG00000183454, GRIN2A, glutamate ionotropic receptor NMDA type subunit 2A, [RH, Score=340, Expect=2e-96]; ENSG00000273079, GRIN2B, glutamate ionotropic receptor NMDA type subunit 2B, [RH, Score=335, Expect=8e-95]; ENSG00000105464, GRIN2D, glutamate ionotropic receptor NMDA type subunit 2D, [RH, Score=330, Expect=3e-93]} {Mouse: ENSMUSG00000059003, Grin2a, glutamate receptor, ionotropic, NMDA2A (epsilon 1), [RH, Score=342, Expect=4e-97]; ENSMUSG00000002771, Grin2d, glutamate receptor, ionotropic, NMDA2D (epsilon 4), [RH, Score=335, Expect=2e-95]; ENSMUSG00000030209, Grin2b, glutamate receptor, ionotropic, NMDA2B (epsilon 2), [RH, Score=335, Expect=9e-95]} {Dmel: FBgn0053513, Nmdar2, NMDA receptor 2, [RH, Score=534, Expect=7e-170]} {Celegans: WBGene00003775, nmr-2, NMDA class glutamate Receptor; NMDA-type ionotropic glutamate receptor NMR-2, [RH, Score=478, Expect=6e-150]} {Smed: dd_Smed_v6_11481_0_1, dd_Smed_v6_11481_0_1, [RH, Score=900, Expect=0.0]} {RNA1509_23999} {RNA1310_1305.1, RNA1509_23999} {RNA1509_23999, RNA815_19439} |
8. | MligTC455_53787 | 269 | 5.6 | Mlig455_023349 | Neo: - Age: Up-Down-Down |
MPDZ | 2.521 | 0.952 | - | 0.851 | 0.718 | - | - | Mlig455_023349 {REF} {Length: 8123} {Pfam: PDZ domain [PF00595.26, score=507.0]; PDZ domain [PF17820.3, score=249.1]; PDZ domain [PF13180.8, score=188.6]; Family of unknown function (DUF6288) [PF19805.1, score=25.5]} {Human: ENSG00000107186, MPDZ, multiple PDZ domain crumbs cell polarity complex component, [Score=421, Expect=2e-118]} {Mouse: ENSMUSG00000028402, Mpdz, multiple PDZ domain protein, [Score=419, Expect=5e-118]} {Dmel: FBgn0067864, Patj, [RH, Score=234, Expect=3e-63]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [RH, Score=174, Expect=3e-43]} {Smed: dd_Smed_v6_5376_0_3, dd_Smed_v6_5376_0_3, [Score=368, Expect=2e-103]} {RNA1509_9181} {RNA1310_504} {RNA815_2967} |
9. | MligTC455_51429 | 110 | 2.29 | Mlig455_024820, Mlig455_024899 | Neo: - Age: Up-Down-Down |
KCNK18 | 2.503 | 0.952 | - | 0.731 | 0.820 | - | - | Mlig455_024820 {REF} {Length: 2654} {Pfam: Ion channel [PF07885.18, score=117.7]; Ion transport protein [PF00520.33, score=25.7]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [RH, Score=102, Expect=6e-23]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=101, Expect=7e-23]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=97.8, Expect=3e-21]} {Dmel: FBgn0033257, sand, sandman, [RH, Score=159, Expect=1e-43]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=171, Expect=4e-48]} {Smed: dd_Smed_v6_19825_0_1, dd_Smed_v6_19825_0_1, [RH, Score=333, Expect=5e-110]} {RNA1509_56216} {RNA1310_14699.1, RNA1509_56216} {RNA1509_56216, RNA815_23055} Mlig455_024899 {REF} {Length: 3465} {Pfam: Ion channel [PF07885.18, score=115.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=113.8]; Ion transport protein [PF00520.33, score=23.7]} {Human: ENSG00000186795, KCNK18, potassium two pore domain channel subfamily K member 18, [RH, Score=101, Expect=2e-22]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=101, Expect=2e-22]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=97.4, Expect=1e-20]} {Dmel: FBgn0033257, sand, sandman, [RH, Score=159, Expect=3e-42]} {Celegans: WBGene00010784, twk-48, TWiK family of potassium channels, [Score=170, Expect=2e-46]} {Smed: dd_Smed_v6_19825_0_1, dd_Smed_v6_19825_0_1, [RH, Score=333, Expect=3e-106]} {RNA1509_56216} {RNA1310_14699.1} {RNA815_252.1} |
10. | MligTC455_50912 | 113 | 2.35 | Mlig455_007288, Mlig455_007301 | Neo: - Age: - Regeneration-upregulated BL: 5.940 Regeneration-enriched BL: 5.940 |
2.451 | 0.995 | - | - | 0.722 | - | 0.734 | Mlig455_007288 {REF} {Length: 870} {RNA1310_55273} {RNA815_57223} Mlig455_007301 {REF} {Length: 845} {NoTransDecoderORF} {RNA1310_55273} {RNA815_57223} |
|
11. | MligTC455_51126 | 48 | 1.01 | Mlig455_036447 | Neo: - Age: - |
GLRA2 | 1.976 | 0.997 | - | 0.979 | - | - | - | Mlig455_036447 {REF} {Length: 2076} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=110.1]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=318, Expect=6e-103]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=316, Expect=5e-102]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=312, Expect=9e-101]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=318, Expect=4e-103]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=317, Expect=3e-102]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=310, Expect=8e-100]} {Dmel: FBgn0024963, GluClalpha, [Score=291, Expect=2e-92]} {Celegans: WBGene00020767, lgc-40, Ligand-Gated ion Channel, [RH, Score=260, Expect=2e-80]} {Smed: dd_Smed_v6_18238_0_1, dd_Smed_v6_18238_0_1, [Score=258, Expect=3e-80]} {RNA1310_34255} {RNA815_61641} |
12. | MligTC455_50582 | 22 | 0.46 | Mlig455_015496 | Neo: - Age: - |
1.936 | - | - | 0.987 | 0.949 | - | - | Mlig455_015496 {REF} {Length: 675} {RNA1509_48973} {RNA1310_27704} {RNA815_36286} | |
13. | MligTC455_09557 | 33 | 0.68 | Mlig455_059478 | Neo: - Age: Up-Down-Down |
B3GNT4 | 1.911 | 0.997 | - | 0.914 | - | - | - | Mlig455_059478 {REF} {Length: 2800} {Pfam: Galactosyltransferase [PF01762.23, score=72.9]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=75.9, Expect=2e-14]} {Mouse: ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=73.6, Expect=1e-13]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=110, Expect=5e-27]} {RNA1310_43488} |
14. | MligTC455_33091 | 131 | 2.74 | Mlig455_022350 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=1.067 Region-enriched R2: 5.543/0.01732 |
GIMAP4 | 1.903 | 0.966 | - | - | - | - | 0.937 | Mlig455_022350 {REF} {Length: 1730} {Pfam: AIG1 family [PF04548.18, score=119.5]; 50S ribosome-binding GTPase [PF01926.25, score=34.5]; Dynamin family [PF00350.25, score=25.0]} {Human: ENSG00000133574, GIMAP4, GTPase, IMAP family member 4, [RH, Score=95.5, Expect=5e-22]} {Mouse: ENSMUSG00000054435, Gimap4, GTPase, IMAP family member 4, [RH, Score=91.7, Expect=2e-21]} {RNA1509_22161} {RNA1310_33853} {RNA815_17084} |
15. | MligTC455_21801 | 58 | 1.22 | Mlig455_015442, Mlig455_032138 | Neo: - Age: - |
NPY1R | 1.891 | - | - | 0.959 | 0.932 | - | - | Mlig455_015442 {REF} {Length: 2461} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=130.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=26.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.9]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=128, Expect=5e-32]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=2e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=140, Expect=4e-36]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=120, Expect=1e-29]} {Smed: dd_Smed_v6_25204_0_1, dd_Smed_v6_25204_0_1, [Score=208, Expect=2e-61]} {RNA1310_49156} {RNA815_43783} Mlig455_032138 {REF} {Length: 2633} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=129.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=126, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=4e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=136, Expect=1e-34]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_25934_0_1, dd_Smed_v6_25934_0_1, [Score=207, Expect=5e-61]} {RNA1310_49156} {RNA815_43783} |
16. | MligTC455_40903 | 29 | 0.6 | Mlig455_050378 | Neo: - Age: - |
1.876 | - | - | 1.000 | 0.876 | - | - | Mlig455_050378 {REF} {Length: 1235} {TRANSSPLICED} {RNA1310_125379} {RNA815_47692} | |
17. | MligTC455_12560 | 18 | 0.37 | Mlig455_059693 | Neo: - Age: - |
1.875 | - | - | 0.997 | 0.878 | - | - | Mlig455_059693 {REF} {Length: 1160} {RNA1310_113662} {RNA815_53854} | |
18. | MligTC455_46043 | 62 | 1.3 | Mlig455_042332 | Neo: - |
1.862 | - | - | 0.956 | 0.906 | - | - | Mlig455_042332 {REF} {Length: 1761} {Pfam: WSC domain [PF01822.21, score=47.9]; PAN domain [PF00024.28, score=19.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=46.2, Expect=8e-06]} {RNA1509_32911} {RNA1310_59750} {RNA815_37535} | |
19. | MligTC455_27684 | 8324 | 173.41 | Mlig455_067482, Mlig455_067490 | Neo: - Age: Down-Up-Up Region-specific R2: 3.632 Region-enriched R2: 2.544/0.00000 |
1.852 | - | - | 0.952 | 0.900 | - | - | Mlig455_067482 {REF} {Length: 709} {RNA1509_3821} {RNA1310_17576.1} {RNA815_6182.1} Mlig455_067490 {REF} {Length: 963} {RNA1509_20366, RNA1509_3821} {RNA1310_17576.1, RNA1509_20366, RNA1509_3821} {RNA1509_20366, RNA1509_3821, RNA815_6182.1} |
|
20. | MligTC455_05870 | 60 | 1.25 | Mlig455_062138 | Neo: - Age: - |
1.851 | 0.965 | - | - | - | 0.886 | - | Mlig455_062138 {REF} {Length: 1049} {NoTransDecoderORF} {RNA1310_117144} | |
21. | MligTC455_12894 | 84 | 1.75 | Mlig455_024418, Mlig455_024572 | Neo: - Age: - Region-enriched R2: 5.211/0.02671 |
SLC46A2 | 1.842 | - | - | 0.965 | 0.877 | - | - | Mlig455_024418 {REF} {Length: 2094} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_44254} {RNA815_43004} Mlig455_024572 {REF} {Length: 1344} {Pfam: Major Facilitator Superfamily [PF07690.18, score=30.9]} {Human: ENSG00000119457, SLC46A2, solute carrier family 46 member 2, [Score=72.4, Expect=2e-13]} {Mouse: ENSMUSG00000020829, Slc46a1, solute carrier family 46, member 1, [Score=55.1, Expect=5e-08]} {Dmel: FBgn0030576, CG15890, [Score=68.9, Expect=1e-12]} {Celegans: WBGene00012811, Y43F8A.5, [Score=65.9, Expect=9e-12]} {Smed: dd_Smed_v6_10822_0_1, dd_Smed_v6_10822_0_1, [Score=187, Expect=2e-55]} {RNA1509_40290} {RNA1310_71457} {RNA815_15082} |
22. | MligTC455_18864 | 264 | 5.51 | Mlig455_022625 | Neo: - Age: Up-Down-Down |
ADAMTS9 | 1.834 | 0.958 | - | - | - | 0.876 | - | Mlig455_022625 {REF} {Length: 7325} {Pfam: Thrombospondin type 1 domain [PF19030.2, score=314.8]; GON domain [PF08685.13, score=123.9]; Thrombospondin type 1 domain [PF00090.21, score=89.6]; ADAM cysteine-rich domain [PF17771.3, score=56.1]; Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=31.0]; Metallo-peptidase family M12 [PF13688.8, score=21.8]; Spondin-like TSP1 domain [PF19028.2, score=20.0]} {Human: ENSG00000163638, ADAMTS9, ADAM metallopeptidase with thrombospondin type 1 motif 9, [RH, Score=544, Expect=9e-160]} {Mouse: ENSMUSG00000030022, Adamts9, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9, [RH, Score=539, Expect=4e-158]} {Dmel: FBgn0038341, AdamTS-A, ADAM metallopeptidase with thrombospondin type 1 motif A, [RH, Score=275, Expect=5e-74]} {Celegans: WBGene00001650, gon-1, A disintegrin and metalloproteinase with thrombospondin motifs gon-1, [RH, Score=521, Expect=2e-151]} {Smed: dd_Smed_v6_10259_0_1, dd_Smed_v6_10259_0_1, [Score=329, Expect=1e-91]} {RNA1509_17892} {RNA1310_1039.1} {RNA815_710} |
23. | MligTC455_25795 | 229 | 4.77 | Mlig455_003545 | Neo: - Age: Down-Down-Up Regeneration-upregulated R6: 2.667 Regeneration-enriched R6: 2.667 |
1.83 | 0.978 | - | - | - | 0.852 | - | Mlig455_003545 {REF} {Length: 2222} {Pfam: Delta serrate ligand [PF01414.21, score=22.0]} {RNA1509_55292} {RNA1310_10852.1, RNA1509_55292} {RNA1509_55292, RNA815_12518} | |
24. | MligTC455_15078 | 100 | 2.09 | Mlig455_026705 | Neo: - Age: Down-Up-Down |
B3GNT6 | 1.829 | - | - | 0.969 | 0.860 | - | - | Mlig455_026705 {REF} {Length: 2083} {Pfam: Galactosyltransferase [PF01762.23, score=135.8]} {Human: ENSG00000198488, B3GNT6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6, [Score=118, Expect=2e-28]} {Mouse: ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=114, Expect=3e-27]} {Dmel: FBgn0035558, CG11357, [Score=146, Expect=3e-38]} {Celegans: WBGene00000270, bre-5, Beta-1,3-galactosyltransferase bre-5, [Score=68.9, Expect=2e-12]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=246, Expect=8e-77]} {RNA1509_8878} {RNA1310_13373} {RNA815_4876} |
25. | MligTC455_38838 | 24 | 0.49 | Mlig455_033571, Mlig455_067059 | Neo: - Age: - |
1.826 | - | - | 0.958 | 0.868 | - | - | Mlig455_033571 {REF} {Length: 1596} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=62.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.7]} {Smed: dd_Smed_v6_42389_0_1, dd_Smed_v6_42389_0_1, [RH, Score=144, Expect=1e-39]} {RNA1310_19511} {RNA815_7578} Mlig455_067059 {REF} {Length: 1559} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=62.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=18.7]} {Smed: dd_Smed_v6_42389_0_1, dd_Smed_v6_42389_0_1, [RH, Score=144, Expect=1e-39]} {RNA1310_19511} {RNA815_7578} |
|
26. | MligTC455_44120 | 125 | 2.61 | Mlig455_041513 | Neo: - Age: Up-Down-Down Region-enriched R2: 7.169/0.00020 |
1.82 | 0.976 | - | - | 0.844 | - | - | Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344} | |
27. | MligTC455_36996 | 285 | 5.93 | Mlig455_050334 | Neo: - Age: - Region-enriched R2: 6.300/0.00168 |
CACNA1C | 1.802 | - | - | 0.984 | 0.818 | - | - | Mlig455_050334 {REF} {Length: 4859} {Pfam: Ion transport protein [PF00520.33, score=618.4]; FAM176 family [PF14851.8, score=22.7]; Polycystin cation channel [PF08016.14, score=21.8]} {Human: ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1126, Expect=0.0]; ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1126, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=1110, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=1073, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=1125, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=1100, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=1219, Expect=0.0]} {Celegans: WBGene00006742, unc-2, High voltage activated calcium channel alpha-1 subunit, [Score=785, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_18, dd_Smed_v6_8899_0_18, [Score=1230, Expect=0.0]} {RNA1509_10231} {RNA1310_369.1, RNA1509_10231} {RNA1509_10231, RNA815_298.1} |
28. | MligTC455_48166 | 242 | 5.05 | Mlig455_030447 | Neo: - Age: Down-Up-Down |
CCNK | 1.799 | 0.977 | - | - | - | 0.822 | - | Mlig455_030447 {REF} {Length: 2396} {TRANSSPLICED} {Pfam: Cyclin, N-terminal domain [PF00134.25, score=58.9]; BAT2 N-terminus [PF07001.13, score=19.3]} {Human: ENSG00000090061, CCNK, cyclin K, [RH, Score=276, Expect=2e-85]} {Mouse: ENSMUSG00000021258, Ccnk, cyclin K, [RH, Score=277, Expect=4e-86]} {Dmel: FBgn0025674, CycK, Cyclin K, [RH, Score=291, Expect=1e-93]} {Celegans: WBGene00009650, ccnk-1, CyCliN K, [RH, Score=152, Expect=1e-42]} {Smed: dd_Smed_v6_2558_1_2, dd_Smed_v6_2558_1_2, [RH, Score=280, Expect=2e-90]} {RNA1509_49990} {RNA1310_8478.1} {RNA815_10830} |
29. | MligTC455_19819 | 67 | 1.39 | Mlig455_042327, Mlig455_047107 | Neo: - Age: - |
1.795 | - | - | 0.995 | 0.800 | - | - | Mlig455_042327 {REF} {Length: 1414} {RNA1310_83687} Mlig455_047107 {REF} {Length: 1283} {RNA1310_83687} |
|
30. | MligTC455_16838 | 75 | 1.57 | Mlig455_030118, Mlig455_030184 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=1.009 Region-enriched R2: 5.681/0.04612 |
1.794 | - | - | 0.963 | 0.831 | - | - | Mlig455_030118 {REF} {Length: 1426} {RNA1310_40798} {RNA815_26160} Mlig455_030184 {REF} {Length: 1426} {RNA1310_40798} {RNA815_26160} |
|
31. | MligTC455_50734 | 175 | 3.66 | Mlig455_044294 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.054/0.00263 |
CHRNA3 | 1.794 | 0.983 | - | - | 0.811 | - | - | Mlig455_044294 {REF} {Length: 1830} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=242.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=225.5]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=373, Expect=1e-123]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=365, Expect=1e-120]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=360, Expect=9e-119]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=358, Expect=6e-118]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=376, Expect=3e-125]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=374, Expect=4e-124]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=450, Expect=4e-154]} {Celegans: WBGene00006797, unc-63, Acetylcholine receptor subunit alpha-type unc-63, [Score=381, Expect=2e-127]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [RH, Score=651, Expect=0.0]} {RNA1509_45903} {RNA1310_14580} {RNA815_10044.1} |
32. | MligTC455_08822 | 204 | 4.26 | Mlig455_021161, Mlig455_057860 | Neo: - Age: - |
GCH1 | 1.792 | 0.984 | - | - | 0.808 | - | - | Mlig455_021161 {REF} {Length: 2321} {Pfam: GTP cyclohydrolase I [PF01227.24, score=244.1]} {Human: ENSG00000131979, GCH1, GTP cyclohydrolase 1, [RH, Score=295, Expect=7e-99]} {Mouse: ENSMUSG00000037580, Gch1, GTP cyclohydrolase 1, [RH, Score=293, Expect=2e-98]} {Dmel: FBgn0003162, Pu, Punch, [Score=276, Expect=2e-91]} {Celegans: WBGene00000298, cat-4, GTP cyclohydrolase 1, [Score=286, Expect=4e-96]} {Smed: dd_Smed_v6_11172_0_1, dd_Smed_v6_11172_0_1, [RH, Score=293, Expect=6e-99]} {RNA1509_45607} {RNA1310_1536.1} {RNA815_18903} Mlig455_057860 {REF} {Length: 1963} {Pfam: GTP cyclohydrolase I [PF01227.24, score=244.0]} {Human: ENSG00000131979, GCH1, GTP cyclohydrolase 1, [RH, Score=294, Expect=1e-98]} {Mouse: ENSMUSG00000037580, Gch1, GTP cyclohydrolase 1, [RH, Score=293, Expect=3e-98]} {Dmel: FBgn0003162, Pu, Punch, [Score=277, Expect=9e-92]} {Celegans: WBGene00000298, cat-4, GTP cyclohydrolase 1, [Score=286, Expect=4e-96]} {Smed: dd_Smed_v6_11172_0_1, dd_Smed_v6_11172_0_1, [RH, Score=294, Expect=3e-99]} {RNA1509_45607} {RNA1310_1536.1} {RNA815_18903} |
33. | MligTC455_43116 | 105 | 2.2 | Mlig455_006245, Mlig455_006299, Mlig455_061192 | Neo: - Age: - |
ESRRB | 1.788 | 0.995 | - | - | 0.793 | - | - | Mlig455_006245 {REF} {Length: 450} {NoTransDecoderORF} Mlig455_006299 {REF} {Length: 2539} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=73.3]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=20.3]} {Human: ENSG00000119715, ESRRB, estrogen related receptor beta, [Score=94.4, Expect=2e-20]} {Mouse: ENSMUSG00000047638, Nr1h4, nuclear receptor subfamily 1, group H, member 4, [Score=88.2, Expect=1e-18]; ENSMUSG00000024955, Esrra, estrogen related receptor, alpha, [Score=86.7, Expect=3e-18]; ENSMUSG00000015846, Rxra, retinoid X receptor alpha, [Score=85.1, Expect=1e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=84.7, Expect=2e-17]} {Dmel: FBgn0035849, ERR, estrogen-related receptor, [Score=80.9, Expect=3e-16]} {Celegans: WBGene00003625, nhr-31, Nuclear hormone receptor family member nhr-31, [Score=84.3, Expect=2e-17]} {Smed: dd_Smed_v6_3012_0_1, dd_Smed_v6_3012_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_86523} Mlig455_061192 {REF} {Length: 2120} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=73.2]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=19.6]} {Human: ENSG00000119715, ESRRB, estrogen related receptor beta, [Score=97.4, Expect=2e-21]} {Mouse: ENSMUSG00000047638, Nr1h4, nuclear receptor subfamily 1, group H, member 4, [Score=94.4, Expect=1e-20]} {Dmel: FBgn0035849, ERR, estrogen-related receptor, [Score=80.1, Expect=4e-16]} {Celegans: WBGene00003625, nhr-31, Nuclear hormone receptor family member nhr-31, [Score=84.3, Expect=2e-17]} {Smed: dd_Smed_v6_13691_0_1, dd_Smed_v6_13691_0_1, [Score=79.7, Expect=1e-16]} {RNA1310_86523} |
34. | MligTC455_33877 | 47 | 0.97 | Mlig455_053914 | Neo: - |
PKD1L2 | 1.786 | - | - | 0.963 | 0.823 | - | - | Mlig455_053914 {REF} {Length: 11153} {Pfam: Polycystin cation channel [PF08016.14, score=263.3]; PKD domain [PF18911.2, score=78.1]; PLAT/LH2 domain [PF01477.25, score=77.6]; PKD domain [PF00801.22, score=77.5]; REJ domain [PF02010.17, score=51.1]; Ion transport protein [PF00520.33, score=32.5]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=236, Expect=4e-61]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=254, Expect=1e-66]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=132, Expect=3e-30]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=134, Expect=1e-30]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=451, Expect=4e-127]} {RNA1509_40400} {RNA1310_23183} {RNA815_27645} |
35. | MligTC455_25443 | 169 | 3.53 | Mlig455_021533 | Neo: - Age: - Region-enriched R2: 2.824/0.01995 |
1.78 | 0.957 | - | 0.823 | - | - | - | Mlig455_021533 {REF} {Length: 138} {NoTransDecoderORF} {RNA1509_48072} {RNA1310_35251} | |
36. | MligTC455_25444 | 369 | 7.69 | Mlig455_021267, Mlig455_021537 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.487/0.04219 |
CACNA1C, CACNA1D | 1.779 | 0.953 | - | 0.826 | - | - | - | Mlig455_021267 {REF} {Length: 9013} {Pfam: Ion transport protein [PF00520.33, score=537.4]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.3]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=91.1]} {Human: ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1303, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1303, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=1277, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=1266, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=1294, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=1281, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=1260, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=1395, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=1340, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_27, dd_Smed_v6_8899_0_27, [Score=1474, Expect=0.0]} {RNA1509_26048} {RNA1310_986.1} {RNA815_1126.1} Mlig455_021537 {REF} {Length: 9107} {Pfam: Ion transport protein [PF00520.33, score=816.0]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=90.6]; Polycystin cation channel [PF08016.14, score=24.2]} {Human: ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [RH, Score=1710, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [RH, Score=1708, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [RH, Score=1734, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [RH, Score=1726, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [RH, Score=1701, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=1863, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [RH, Score=1798, Expect=0.0]} {Smed: dd_Smed_v6_8899_0_23, dd_Smed_v6_8899_0_23, [RH, Score=1973, Expect=0.0]} {RNA1509_41912} {RNA1310_869} {RNA815_1126.1} |
37. | MligTC455_42217 | 16 | 0.34 | Mlig455_035749 | Neo: - Age: - |
OSR1 | 1.77 | - | - | 0.950 | 0.820 | - | - | Mlig455_035749 {REF} {Length: 1970} {Human: ENSG00000143867, OSR1, odd-skipped related transciption factor 1, [Score=55.8, Expect=3e-08]; ENSG00000164920, OSR2, odd-skipped related transciption factor 2, [Score=53.9, Expect=1e-07]} {Mouse: ENSMUSG00000048387, Osr1, odd-skipped related transcription factor 1, [Score=56.2, Expect=2e-08]; ENSMUSG00000022330, Osr2, odd-skipped related 2, [Score=54.3, Expect=8e-08]} {Dmel: FBgn0002985, odd, odd skipped, [Score=53.1, Expect=2e-07]} {Celegans: WBGene00003846, odd-2, Protein odd-skipped-related 2, [Score=54.3, Expect=3e-08]} {Smed: dd_Smed_v6_10039_0_1, dd_Smed_v6_10039_0_1, [Score=57.8, Expect=2e-09]} {RNA1509_57522} {RNA1310_26149} {RNA815_39133} |
38. | MligTC455_10599 | 140 | 2.91 | Mlig455_000565, Mlig455_030365, Mlig455_030412 | Neo: - Age: logFC(26M/2M)=-0.762 |
GRIK3 | 1.765 | - | - | 0.972 | 0.793 | - | - | Mlig455_000565 {REF} {Length: 2846} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=56.1]; Ligand-gated ion channel [PF00060.28, score=44.5]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=145, Expect=3e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=142, Expect=3e-34]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=141, Expect=5e-34]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=139, Expect=3e-33]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=144, Expect=5e-35]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=140, Expect=9e-34]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=139, Expect=2e-33]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=138, Expect=5e-33]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=138, Expect=4e-33]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=130, Expect=1e-30]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=135, Expect=3e-32]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=154, Expect=2e-38]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} Mlig455_030365 {REF} {Length: 2765} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.6]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=57.7]; Ligand-gated ion channel [PF00060.28, score=43.6]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=144, Expect=6e-35]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=140, Expect=2e-33]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=138, Expect=7e-33]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=138, Expect=7e-33]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=137, Expect=2e-32]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=142, Expect=2e-34]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=142, Expect=2e-34]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=138, Expect=4e-33]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=136, Expect=2e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=136, Expect=2e-32]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=130, Expect=6e-31]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=131, Expect=3e-31]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=155, Expect=7e-39]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} Mlig455_030412 {REF} {Length: 2615} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.2]; Ligand-gated ion channel [PF00060.28, score=45.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=36.1]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=125, Expect=6e-29]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=122, Expect=6e-28]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=121, Expect=1e-27]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=125, Expect=4e-29]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=124, Expect=6e-29]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=120, Expect=2e-27]} {Dmel: FBgn0026255, clumsy, [Score=117, Expect=9e-27]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=117, Expect=7e-27]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=135, Expect=1e-32]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} |
39. | MligTC455_46391 | 204 | 4.24 | Mlig455_034052, Mlig455_034075 | Neo: - Age: - |
1.764 | 0.980 | - | - | - | - | 0.784 | Mlig455_034052 {REF} {Length: 1129} {TRANSSPLICED} {Pfam: Sleepless protein [PF17064.7, score=37.0]} {Dmel: FBgn0260499, qvr, quiver, [RH, Score=80.5, Expect=2e-19]} {Smed: dd_Smed_v6_16907_0_2, dd_Smed_v6_16907_0_2, [Score=75.1, Expect=1e-17]} {RNA1310_53545} {RNA815_30194} Mlig455_034075 {REF} {Length: 1159} {Pfam: Sleepless protein [PF17064.7, score=36.8]} {Dmel: FBgn0260499, qvr, quiver, [RH, Score=78.6, Expect=9e-19]} {Smed: dd_Smed_v6_16907_0_2, dd_Smed_v6_16907_0_2, [Score=78.6, Expect=6e-19]} {RNA1310_53545} {RNA815_30194} |
|
40. | MligTC455_07509 | 24 | 0.49 | Mlig455_064490 | Neo: - Age: - |
1.762 | - | - | - | 0.801 | 0.961 | - | Mlig455_064490 {REF} {Length: 556} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_28076} | |
41. | MligTC455_20630 | 49 | 1.03 | Mlig455_015973 | Neo: - Age: - |
CHRND | 1.762 | - | - | - | 0.982 | - | 0.780 | Mlig455_015973 {REF} {Length: 1842} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=127.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=22.4]} {Human: ENSG00000135902, CHRND, cholinergic receptor nicotinic delta subunit, [Score=118, Expect=6e-29]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=115, Expect=5e-28]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=114, Expect=2e-27]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=114, Expect=2e-27]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=113, Expect=5e-27]} {Mouse: ENSMUSG00000026251, Chrnd, cholinergic receptor, nicotinic, delta polypeptide, [Score=117, Expect=2e-28]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=112, Expect=4e-27]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=112, Expect=4e-27]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=114, Expect=1e-27]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=123, Expect=5e-31]} {Smed: dd_Smed_v6_29533_0_1, dd_Smed_v6_29533_0_1, [Score=177, Expect=3e-51]} {RNA1310_42200} {RNA815_41928} |
42. | MligTC455_44621 | 211 | 4.4 | Mlig455_002926, Mlig455_002944 | Neo: - Age: Down-Up-Down |
SNX1 | 1.761 | 0.986 | - | - | - | - | 0.775 | Mlig455_002926 {REF} {Length: 3070} {TRANSSPLICED} {Pfam: Vps5 C terminal like [PF09325.12, score=95.8]; PX domain [PF00787.26, score=40.3]} {Human: ENSG00000028528, SNX1, sorting nexin 1, [Score=152, Expect=2e-40]} {Mouse: ENSMUSG00000032382, Snx1, sorting nexin 1, [Score=151, Expect=7e-40]; ENSMUSG00000034484, Snx2, sorting nexin 2, [Score=144, Expect=2e-37]} {Dmel: FBgn0031534, Snx1, Sorting nexin 1, [Score=139, Expect=3e-36]} {Smed: dd_Smed_v6_835_0_2, dd_Smed_v6_835_0_2, [Score=165, Expect=6e-46]} {RNA1310_29392.1} {RNA815_34615} Mlig455_002944 {REF} {Length: 2843} {TRANSSPLICED} {Pfam: Vps5 C terminal like [PF09325.12, score=97.9]; PX domain [PF00787.26, score=40.3]} {Human: ENSG00000028528, SNX1, sorting nexin 1, [Score=154, Expect=2e-41]} {Mouse: ENSMUSG00000032382, Snx1, sorting nexin 1, [Score=153, Expect=1e-40]; ENSMUSG00000034484, Snx2, sorting nexin 2, [Score=146, Expect=2e-38]} {Dmel: FBgn0031534, Snx1, Sorting nexin 1, [Score=139, Expect=3e-36]} {Smed: dd_Smed_v6_835_0_2, dd_Smed_v6_835_0_2, [Score=167, Expect=8e-47]} {RNA1310_29392.1} {RNA815_34615} |
43. | MligTC455_16311 | 89 | 1.86 | Mlig455_053827, Mlig455_068518 | Neo: - Age: - Region-enriched R2: 5.249/0.01530 |
CALML3 | 1.744 | - | - | 0.966 | 0.778 | - | - | Mlig455_053827 {REF} {Length: 1659} {Pfam: EF-hand domain pair [PF13499.8, score=64.3]; EF hand [PF00036.34, score=58.1]; EF-hand domain [PF13405.8, score=55.1]; EF hand [PF13202.8, score=37.9]; EF-hand domain pair [PF13833.8, score=32.8]; EF-hand domain [PF14658.8, score=20.4]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=96.7, Expect=3e-25]; ENSG00000143933, CALM2, calmodulin 2, [Score=96.7, Expect=6e-25]; ENSG00000198668, CALM1, calmodulin 1, [Score=96.3, Expect=3e-25]; ENSG00000160014, CALM3, calmodulin 3, [Score=96.3, Expect=3e-25]} {Mouse: ENSMUSG00000036438, Calm2, calmodulin 2, [Score=96.3, Expect=2e-25]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=96.3, Expect=2e-25]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=96.3, Expect=2e-25]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=95.9, Expect=2e-25]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=97.1, Expect=7e-26]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=97.4, Expect=5e-26]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=97.4, Expect=4e-26]} {RNA1509_37850} {RNA1310_5623.1} {RNA815_35579} Mlig455_068518 {REF} {Length: 1007} {Pfam: EF-hand domain pair [PF13499.8, score=64.3]; EF hand [PF00036.34, score=58.1]; EF-hand domain [PF13405.8, score=55.1]; EF hand [PF13202.8, score=38.0]; EF-hand domain pair [PF13833.8, score=33.0]; EF-hand domain [PF14658.8, score=20.4]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=96.7, Expect=2e-25]; ENSG00000143933, CALM2, calmodulin 2, [Score=96.7, Expect=6e-25]; ENSG00000160014, CALM3, calmodulin 3, [Score=96.3, Expect=3e-25]; ENSG00000198668, CALM1, calmodulin 1, [Score=96.3, Expect=3e-25]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=96.3, Expect=2e-25]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=96.3, Expect=2e-25]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=96.3, Expect=2e-25]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=95.9, Expect=3e-25]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=97.1, Expect=7e-26]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=97.1, Expect=5e-26]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=97.1, Expect=4e-26]} {RNA1509_37850} {RNA1310_5623.1} {RNA815_35579} |
44. | MligTC455_38543 | 146 | 3.03 | Mlig455_017595 | Neo: - Age: - Region-enriched R3: 2.925/0.03259 |
1.737 | 0.988 | - | 0.749 | - | - | - | Mlig455_017595 {REF} {Length: 1878} {RNA1310_40211} {RNA815_8698} | |
45. | MligTC455_36609 | 196 | 4.08 | Mlig455_018538 | Neo: - Age: - |
ANKRD18B | 1.735 | 0.984 | - | - | - | - | 0.751 | Mlig455_018538 {REF} {Length: 4748} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=80.9]; Ankyrin repeats (many copies) [PF13637.8, score=66.0]; Ankyrin repeat [PF00023.32, score=58.7]; Ankyrin repeats (many copies) [PF13857.8, score=55.5]; Ankyrin repeat [PF13606.8, score=52.9]} {Human: ENSG00000230453, ANKRD18B, ankyrin repeat domain 18B, [RH, Score=105, Expect=4e-22]} {Mouse: ENSMUSG00000022246, Rai14, retinoic acid induced 14, [Score=100, Expect=8e-21]; ENSMUSG00000020481, Ankrd36, ankyrin repeat domain 36, [Score=96.3, Expect=2e-19]; ENSMUSG00000029517, Ankrd7, ankyrin repeat domain 7, [Score=95.9, Expect=5e-21]} {Dmel: FBgn0037759, CG8526, [Score=68.9, Expect=2e-11]} {Celegans: WBGene00004053, tank-1, Tankyrase-like protein, [Score=72.0, Expect=3e-12]} {Smed: dd_Smed_v6_7813_0_1, dd_Smed_v6_7813_0_1, [Score=82.4, Expect=6e-16]} {RNA1509_17141} {RNA1310_571} {RNA815_5717} |
46. | MligTC455_16216 | 158 | 3.3 | Mlig455_068299 | Neo: - Age: logFC(26M/2M)=0.459 |
AXIN2 | 1.732 | 0.962 | - | - | - | 0.770 | - | Mlig455_068299 {REF} {Length: 5180} {TRANSSPLICED} {Pfam: DIX domain [PF00778.19, score=84.1]; Regulator of G protein signaling domain [PF00615.21, score=28.6]} {Human: ENSG00000168646, AXIN2, axin 2, [Score=129, Expect=2e-30]} {Mouse: ENSMUSG00000000142, Axin2, axin 2, [Score=110, Expect=1e-24]} {Dmel: FBgn0026597, Axn, Axin, [RH, Score=68.9, Expect=1e-11]} {Smed: dd_Smed_v6_4900_0_1, dd_Smed_v6_4900_0_1, [RH, Score=114, Expect=2e-26]} {RNA1509_26666, RNA1509_46700} {RNA1310_18759, RNA1509_46700} {RNA1509_46700, RNA815_19659} |
47. | MligTC455_40779 | 191 | 3.98 | Mlig455_000277, Mlig455_035731, Mlig455_058356 | Neo: - Age: - Region-enriched R4: 3.665/0.04268 |
1.73 | 0.993 | - | 0.737 | - | - | - | Mlig455_000277 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_035731 {REF} {Length: 1048} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} Mlig455_058356 {REF} {Length: 1050} {RNA1509_16458} {RNA1310_43664.1} {RNA815_23166} |
|
48. | MligTC455_48455 | 161 | 3.36 | Mlig455_042005 | Neo: - Age: logFC(26M/2M)=-0.488 |
CCDC154 | 1.73 | 0.975 | - | - | - | - | 0.755 | Mlig455_042005 {REF} {Length: 3899} {Pfam: Coiled-coil domain-containing protein 154 [PF15450.8, score=125.4]} {Human: ENSG00000197599, CCDC154, coiled-coil domain containing 154, [RH, Score=122, Expect=5e-28]} {Mouse: ENSMUSG00000059562, Ccdc154, coiled-coil domain containing 154, [RH, Score=114, Expect=1e-25]} {Dmel: FBgn0002526, LanA, Laminin A, [Score=50.4, Expect=7e-06]} {Celegans: WBGene00016032, C24A3.1, [RH, Score=65.9, Expect=7e-11]} {Smed: dd_Smed_v6_10236_0_1, dd_Smed_v6_10236_0_1, [RH, Score=450, Expect=1e-146]} {RNA1509_5383} {RNA1310_2073.1} {RNA815_2050} |
49. | MligTC455_36667 | 84 | 1.75 | Mlig455_016177 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.440 Region-enriched R2: 4.490/0.00556 |
1.727 | 0.984 | - | - | - | - | 0.743 | Mlig455_016177 {REF} {Length: 3035} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=47.6]; Immunoglobulin domain [PF13927.8, score=47.0]; Immunoglobulin domain [PF00047.27, score=32.1]; Immunoglobulin domain [PF13895.8, score=27.4]; Natural killer cell receptor 2B4 [PF11465.10, score=26.4]; Immunoglobulin V-set domain [PF07686.19, score=23.5]} {Dmel: FBgn0259245, DIP-beta, Dpr-interacting protein beta, [Score=58.9, Expect=3e-09]} {Celegans: WBGene00006985, zig-8, Zwei Ig domain protein zig-8, [RH, Score=57.0, Expect=4e-09]} {Smed: dd_Smed_v6_21969_0_1, dd_Smed_v6_21969_0_1, [Score=72.0, Expect=6e-14]} {RNA1509_49618} {RNA1310_15195} {RNA815_58259} | |
50. | MligTC455_29057 | 679 | 14.15 | Mlig455_011099, Mlig455_011100, Mlig455_058074 | Neo: - |
1.723 | 0.961 | - | 0.762 | - | - | - | Mlig455_011099 {REF} {Length: 418} {NoTransDecoderORF} {RNA1509_12781} {RNA1310_63.1} {RNA815_23.1} Mlig455_011100 {REF} {Length: 2335} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_54862} {RNA1310_63.1, RNA1509_54862} {RNA1509_54862, RNA815_5170.1} Mlig455_058074 {REF} {Length: 5149} {RNA1509_26411} {RNA1310_63.1, RNA1509_26411} {RNA1509_26411, RNA815_23.1} |
|
51. | MligTC455_41883 | 85 | 1.77 | Mlig455_012612 | Neo: - Age: - |
ANKRD50 | 1.719 | 0.974 | - | - | 0.745 | - | - | Mlig455_012612 {REF} {Length: 7141} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=77.8]; Ankyrin repeats (many copies) [PF13637.8, score=63.2]; Ankyrin repeats (many copies) [PF13857.8, score=53.8]; Ankyrin repeat [PF13606.8, score=46.8]; Mab-21 protein [PF03281.16, score=41.3]; Ankyrin repeat [PF00023.32, score=37.7]; Helix-turn-helix domain [PF13560.8, score=18.9]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=86.3, Expect=2e-16]; ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=83.6, Expect=1e-15]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=87.4, Expect=6e-17]} {Dmel: FBgn0041096, rols, rolling pebbles, [Score=91.7, Expect=2e-18]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=64.7, Expect=3e-10]} {Smed: dd_Smed_v6_6779_0_1, dd_Smed_v6_6779_0_1, [Score=89.7, Expect=5e-18]} {RNA1509_27676, RNA1509_27730} {RNA1310_22442, RNA1509_27676} {RNA1509_27676, RNA815_2426.1} |
52. | MligTC455_16173 | 125 | 2.6 | Mlig455_039164 | Neo: - Age: - |
PHLPP2 | 1.711 | 0.961 | - | - | - | 0.750 | - | Mlig455_039164 {REF} {Length: 6351} {Pfam: Leucine rich repeat [PF13855.8, score=125.1]; Leucine Rich repeats (2 copies) [PF12799.9, score=95.0]; Protein phosphatase 2C [PF00481.23, score=72.3]; Leucine-rich repeat [PF14580.8, score=18.5]} {Human: ENSG00000040199, PHLPP2, PH domain and leucine rich repeat protein phosphatase 2, [Score=382, Expect=8e-111]; ENSG00000081913, PHLPP1, PH domain and leucine rich repeat protein phosphatase 1, [Score=367, Expect=5e-104]} {Mouse: ENSMUSG00000031732, Phlpp2, PH domain and leucine rich repeat protein phosphatase 2, [Score=375, Expect=2e-108]; ENSMUSG00000044340, Phlpp1, PH domain and leucine rich repeat protein phosphatase 1, [Score=370, Expect=3e-105]} {Dmel: FBgn0032749, Phlpp, PH domain leucine-rich repeat protein phosphatase, [Score=186, Expect=1e-47]} {Celegans: WBGene00009647, phlp-2, Protein phosphatase PHLPP-like protein, [Score=268, Expect=2e-73]} {Smed: dd_Smed_v6_5407_0_1, dd_Smed_v6_5407_0_1, [Score=104, Expect=3e-22]} {RNA1509_32447} {RNA1310_1676.1} {RNA815_1956} |
53. | MligTC455_07352 | 9 | 0.19 | Mlig455_030939 | Neo: - Age: - |
1.71 | - | - | 0.749 | - | 0.961 | - | Mlig455_030939 {REF} {Length: 127} {NoTransDecoderORF} {RNA1310_33202} | |
54. | MligTC455_17034 | 20 | 0.43 | Mlig455_035071, Mlig455_035141, Mlig455_035146 | Neo: - Age: - |
1.71 | - | - | 0.749 | - | 0.961 | - | Mlig455_035071 {REF} {Length: 142} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_6064} {RNA1310_22222} {RNA815_2375} Mlig455_035141 {REF} {Length: 142} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_6064} {RNA1310_22222} {RNA815_2375} Mlig455_035146 {REF} {Length: 146} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_6064} {RNA1310_4462} {RNA815_2375} |
|
55. | MligTC455_52480 | 25 | 0.51 | Mlig455_040937 | Neo: - Age: - |
1.707 | 0.981 | - | - | 0.726 | - | - | Mlig455_040937 {REF} {Length: 2050} {RNA1310_86606} {RNA815_50003.1} | |
56. | MligTC455_52746 | 33 | 0.7 | Mlig455_036774 | Neo: - Age: - |
1.706 | - | - | 0.978 | - | - | 0.728 | Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348} | |
57. | MligTC455_12113 | 72 | 1.5 | Mlig455_001687, Mlig455_071131 | Neo: - Age: - |
1.704 | - | - | 0.731 | 0.973 | - | - | Mlig455_001687 {REF} {Length: 809} {RNA1310_67367} {RNA815_37220} Mlig455_071131 {REF} {Length: 452} {RNA1509_45496} {RNA1310_67367} {RNA815_37220} |
|
58. | MligTC455_38459 | 45 | 0.93 | Mlig455_039511 | Neo: - Age: - |
1.702 | 0.980 | - | - | - | 0.722 | - | Mlig455_039511 {REF} {Length: 1763} {RNA1310_28882} {RNA815_36271} | |
59. | MligTC455_40781 | 153 | 3.2 | Mlig455_024109, Mlig455_063982 | Neo: - Age: - |
1.7 | 0.988 | - | 0.712 | - | - | - | Mlig455_024109 {REF} {Length: 1081} {RNA1509_16458} {RNA1310_43664.1, RNA1509_16458} {RNA1509_16458, RNA815_23166} Mlig455_063982 {REF} {Length: 3562} {RNA1509_16458} {RNA1310_30070} {RNA815_23166} |
|
60. | MligTC455_50326 | 349 | 7.27 | Mlig455_000563, Mlig455_030362 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.949/0.00096 |
ARID3A | 1.7 | 0.977 | - | 0.723 | - | - | - | Mlig455_000563 {REF} {Length: 2916} {Pfam: ARID/BRIGHT DNA binding domain [PF01388.23, score=72.3]} {Human: ENSG00000116017, ARID3A, AT-rich interaction domain 3A, [RH, Score=244, Expect=4e-74]; ENSG00000205143, ARID3C, AT-rich interaction domain 3C, [RH, Score=244, Expect=5e-73]; ENSG00000179361, ARID3B, AT-rich interaction domain 3B, [RH, Score=236, Expect=3e-68]} {Mouse: ENSMUSG00000019564, Arid3a, AT rich interactive domain 3A (BRIGHT-like), [RH, Score=247, Expect=3e-72]; ENSMUSG00000066224, Arid3c, AT rich interactive domain 3C (BRIGHT-like), [RH, Score=247, Expect=2e-74]; ENSMUSG00000004661, Arid3b, AT rich interactive domain 3B (BRIGHT-like), [RH, Score=235, Expect=4e-68]} {Dmel: FBgn0004795, retn, retained, [RH, Score=244, Expect=7e-69]} {Celegans: WBGene00000476, cfi-1, AT-rich interactive domain-containing protein cfi-1, [RH, Score=229, Expect=6e-67]} {Smed: dd_Smed_v6_13474_0_1, dd_Smed_v6_13474_0_1, [RH, Score=257, Expect=3e-76]} {RNA1310_43081} {RNA815_22524} Mlig455_030362 {REF} {Length: 2929} {Pfam: ARID/BRIGHT DNA binding domain [PF01388.23, score=72.3]} {Human: ENSG00000116017, ARID3A, AT-rich interaction domain 3A, [RH, Score=241, Expect=9e-73]; ENSG00000205143, ARID3C, AT-rich interaction domain 3C, [RH, Score=241, Expect=6e-72]; ENSG00000179361, ARID3B, AT-rich interaction domain 3B, [RH, Score=233, Expect=4e-67]} {Mouse: ENSMUSG00000066224, Arid3c, AT rich interactive domain 3C (BRIGHT-like), [RH, Score=244, Expect=1e-73]; ENSMUSG00000019564, Arid3a, AT rich interactive domain 3A (BRIGHT-like), [RH, Score=243, Expect=7e-71]; ENSMUSG00000004661, Arid3b, AT rich interactive domain 3B (BRIGHT-like), [RH, Score=232, Expect=6e-67]} {Dmel: FBgn0004795, retn, retained, [RH, Score=240, Expect=1e-67]} {Celegans: WBGene00000476, cfi-1, AT-rich interactive domain-containing protein cfi-1, [RH, Score=229, Expect=5e-67]} {Smed: dd_Smed_v6_13474_0_1, dd_Smed_v6_13474_0_1, [RH, Score=258, Expect=2e-76]} {RNA1310_43081} {RNA815_22524} |
61. | MligTC455_46046 | 18 | 0.37 | Mlig455_042344 | Neo: - Age: - |
ASL | 1.694 | - | - | 0.737 | 0.957 | - | - | Mlig455_042344 {REF} {Length: 1218} {Pfam: Lyase [PF00206.22, score=41.7]; WSC domain [PF01822.21, score=31.1]} {Human: ENSG00000126522, ASL, argininosuccinate lyase, [Score=77.8, Expect=4e-16]} {Mouse: ENSMUSG00000025533, Asl, argininosuccinate lyase, [Score=76.3, Expect=8e-16]} {Dmel: FBgn0032076, CG9510, [Score=70.5, Expect=6e-14]} {Smed: dd_Smed_v6_3792_0_1, dd_Smed_v6_3792_0_1, [Score=86.7, Expect=9e-20]} {RNA1509_17568} {RNA1310_77268} {RNA815_37535} |
62. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 1.69 | 0.990 | - | - | - | - | 0.700 | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
63. | MligTC455_46748 | 216 | 4.51 | Mlig455_012842 | Neo: - Age: Down-Up-Up |
1.69 | 0.956 | 0.734 | - | - | - | - | Mlig455_012842 {REF} {Length: 1460} {Pfam: MIT (microtubule interacting and transport) domain [PF04212.20, score=25.1]} {RNA1310_28416.2} {RNA815_36900} | |
64. | MligTC455_17003 | 32 | 0.66 | Mlig455_011034 | Neo: - |
P2RX2 | 1.685 | - | - | - | 0.950 | - | 0.735 | Mlig455_011034 {REF} {Length: 2894} {Pfam: ATP P2X receptor [PF00864.21, score=288.1]} {Human: ENSG00000187848, P2RX2, purinergic receptor P2X 2, [Score=206, Expect=3e-60]; ENSG00000135124, P2RX4, purinergic receptor P2X 4, [Score=201, Expect=7e-59]} {Mouse: ENSMUSG00000029503, P2rx2, purinergic receptor P2X, ligand-gated ion channel, 2, [Score=202, Expect=8e-59]} {Smed: dd_Smed_v6_10968_0_1, dd_Smed_v6_10968_0_1, [Score=269, Expect=3e-84]} {RNA1509_56054} {RNA1310_31414} {RNA815_43099} |
65. | MligTC455_25761 | 8 | 0.17 | Mlig455_002214 | Neo: - Age: - |
1.684 | - | - | 0.726 | - | 0.958 | - | Mlig455_002214 {REF} {Length: 2219} {RNA1509_23358} {RNA1310_81622} {RNA815_55072.1} | |
66. | MligTC455_18501 | 200 | 4.16 | Mlig455_031954 | Neo: - Age: Down-Up-Up |
1.682 | 0.952 | - | 0.730 | - | - | - | Mlig455_031954 {REF} {Length: 1030} {RNA1509_49054} {RNA1310_32906} {RNA815_15169} | |
67. | MligTC455_49724 | 103 | 2.14 | Mlig455_063517 | Neo: - Age: - |
PRR9 | 1.682 | - | - | 0.955 | 0.727 | - | - | Mlig455_063517 {REF} {Length: 1834} {Human: ENSG00000203783, PRR9, proline rich 9, [Score=47.4, Expect=9e-07]} {Celegans: WBGene00018026, F35A5.4, [Score=59.3, Expect=2e-10]} {RNA1509_59537} {RNA1310_56082} {RNA815_50844} |
68. | MligTC455_40467 | 376 | 7.84 | Mlig455_023012 | Neo: - Age: - |
1.681 | 0.956 | - | - | - | - | 0.725 | Mlig455_023012 {REF} {Length: 944} {Celegans: WBGene00015646, mlt-10, [Score=150, Expect=4e-42]} {RNA1509_41640} {RNA1310_84380.1} {RNA815_12512} | |
69. | MligTC455_40468 | 380 | 7.91 | Mlig455_023112 | Neo: - |
LRRC72 | 1.679 | 0.956 | - | - | - | - | 0.723 | Mlig455_023112 {REF} {Length: 1305} {Pfam: Leucine-rich repeat [PF14580.8, score=70.4]; Leucine Rich repeats (2 copies) [PF12799.9, score=39.2]; Leucine rich repeat [PF13855.8, score=23.3]} {Human: ENSG00000205858, LRRC72, leucine rich repeat containing 72, [RH, Score=130, Expect=7e-36]} {Mouse: ENSMUSG00000020545, Lrrc72, leucine rich repeat containing 72, [RH, Score=140, Expect=2e-39]} {Dmel: FBgn0014395, tilB, touch insensitive larva B, [Score=50.4, Expect=8e-07]} {Celegans: WBGene00003390, mog-2, Probable U2 small nuclear ribonucleoprotein A', [Score=73.2, Expect=5e-15]} {Smed: dd_Smed_v6_5405_0_1, dd_Smed_v6_5405_0_1, [Score=60.5, Expect=1e-10]} {RNA1509_41640, RNA1509_50261} {RNA1310_32093.1, RNA1509_41640, RNA1509_50261} {RNA1509_41640, RNA1509_50261, RNA815_12512} |
70. | MligTC455_41399 | 147 | 3.07 | Mlig455_028472, Mlig455_028497 | Neo: - Age: - Region-enriched R4: 3.401/0.01137 |
FADS2 | 1.678 | 0.962 | - | - | - | - | 0.716 | Mlig455_028472 {REF} {Length: 2155} {Pfam: Fatty acid desaturase [PF00487.26, score=111.7]} {Human: ENSG00000134824, FADS2, fatty acid desaturase 2, [Score=348, Expect=8e-118]; ENSG00000149485, FADS1, fatty acid desaturase 1, [Score=339, Expect=4e-115]} {Mouse: ENSMUSG00000024665, Fads2, fatty acid desaturase 2, [Score=357, Expect=4e-121]} {Celegans: WBGene00001395, fat-3, Delta(6)-fatty-acid desaturase fat-3, [Score=107, Expect=1e-26]} {Smed: dd_Smed_v6_10869_0_1, dd_Smed_v6_10869_0_1, [Score=418, Expect=1e-145]} {RNA1509_26943} {RNA1310_8517.1} {RNA815_15928} Mlig455_028497 {REF} {Length: 2199} {TRANSSPLICED} {Pfam: Fatty acid desaturase [PF00487.26, score=113.5]; Cytochrome b5-like Heme/Steroid binding domain [PF00173.30, score=60.8]} {Human: ENSG00000134824, FADS2, fatty acid desaturase 2, [Score=409, Expect=5e-140]; ENSG00000149485, FADS1, fatty acid desaturase 1, [Score=402, Expect=3e-136]} {Mouse: ENSMUSG00000024665, Fads2, fatty acid desaturase 2, [Score=422, Expect=4e-145]} {Dmel: FBgn0264294, Cyt-b5, Cytochrome b5, [Score=47.0, Expect=3e-06]} {Celegans: WBGene00001395, fat-3, Delta(6)-fatty-acid desaturase fat-3, [Score=121, Expect=4e-30]} {Smed: dd_Smed_v6_10869_0_1, dd_Smed_v6_10869_0_1, [RH, Score=476, Expect=3e-167]} {RNA1509_26943} {RNA1310_8517.1} {RNA815_15928} |
71. | MligTC455_50664 | 138 | 2.87 | Mlig455_035152 | Neo: - Age: - Region-enriched R2: 3.712/0.01441 |
LRRC74A | 1.678 | 0.970 | - | - | - | - | 0.708 | Mlig455_035152 {REF} {Length: 2523} {TRANSSPLICED} {Pfam: Leucine Rich repeat [PF13516.8, score=68.7]; Leucine Rich Repeat [PF00560.35, score=35.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=31.8]; Leucine rich repeat [PF13855.8, score=22.7]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=146, Expect=1e-37]; ENSG00000187905, LRRC74B, leucine rich repeat containing 74B, [Score=144, Expect=1e-37]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=147, Expect=5e-38]; ENSMUSG00000022759, Lrrc74b, leucine rich repeat containing 74B, [Score=144, Expect=1e-37]} {Dmel: FBgn0033212, LRR, Leucine-rich repeat, [Score=51.6, Expect=2e-06]} {Celegans: WBGene00009201, F28C1.3, Protein phosphatase 1 regulatory subunit 37 homolog, [Score=55.5, Expect=8e-08]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=147, Expect=6e-38]} {RNA1509_21228} {RNA1310_12842} {RNA815_17243} |
72. | MligTC455_49718 | 757 | 15.78 | Mlig455_068225 | Neo: - Age: - Regeneration-enriched BL: 2.363 |
NLK | 1.676 | 0.955 | - | 0.721 | - | - | - | Mlig455_068225 {REF} {Length: 2645} {Pfam: Protein kinase domain [PF00069.27, score=205.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=99.2]; ABC1 atypical kinase-like domain [PF03109.18, score=21.1]; Fungal protein kinase [PF17667.3, score=19.9]} {Human: ENSG00000087095, NLK, nemo like kinase, [RH, Score=438, Expect=1e-149]} {Mouse: ENSMUSG00000017376, Nlk, nemo like kinase, [RH, Score=438, Expect=7e-150]} {Dmel: FBgn0011817, nmo, nemo, [RH, Score=442, Expect=8e-153]} {Celegans: WBGene00003048, lit-1, Serine/threonine kinase NLK, [RH, Score=402, Expect=1e-136]} {Smed: dd_Smed_v6_4172_0_3, dd_Smed_v6_4172_0_3, [RH, Score=416, Expect=2e-142]} {RNA1509_20551} {RNA1310_9465} {RNA815_12333} |
73. | MligTC455_39694 | 73 | 1.51 | Mlig455_021504, Mlig455_067393 | Neo: - Age: - |
1.672 | 0.971 | - | 0.701 | - | - | - | Mlig455_021504 {REF} {Length: 1105} {Pfam: Chromatin assembly factor 1 complex p150 subunit, N-terminal [PF11600.10, score=25.0]} {Smed: dd_Smed_v6_2373_0_1, dd_Smed_v6_2373_0_1, [Score=70.9, Expect=4e-13]} {RNA1509_19671} {RNA1310_1157} {RNA815_38185} Mlig455_067393 {REF} {Length: 3563} {Smed: dd_Smed_v6_2373_0_2, dd_Smed_v6_2373_0_2, [Score=112, Expect=4e-25]} {RNA1509_19671} {RNA1310_1157} {RNA815_36782} |
|
74. | MligTC455_18771 | 659 | 13.72 | Mlig455_016920, Mlig455_017020 | Neo: - Age: - Region-enriched R2: 5.606/0.00193 |
1.667 | - | - | 0.959 | 0.708 | - | - | Mlig455_016920 {REF} {Length: 860} {RNA1509_33769} {RNA1310_80187.1} {RNA815_43341.1} Mlig455_017020 {REF} {Length: 769} {RNA1509_33769} {RNA1310_80187.1, RNA1509_33769} {RNA1509_33769, RNA815_43341.1} |
|
75. | MligTC455_21946 | 173 | 3.59 | Mlig455_018218 | Neo: - Age: - Region-enriched R2: 3.881/0.00497 |
CDH18 | 1.666 | 0.960 | - | - | - | - | 0.706 | Mlig455_018218 {REF} {Length: 4227} {Pfam: Cadherin cytoplasmic region [PF01049.19, score=86.9]; Laminin G domain [PF02210.26, score=84.1]; Laminin G domain [PF00054.25, score=59.1]; EGF-like domain [PF00008.29, score=34.5]; Human growth factor-like EGF [PF12661.9, score=20.0]} {Human: ENSG00000145526, CDH18, cadherin 18, [Score=107, Expect=3e-23]} {Mouse: ENSMUSG00000040420, Cdh18, cadherin 18, [Score=107, Expect=3e-23]; ENSMUSG00000107269, Celsr3, cadherin, EGF LAG seven-pass G-type receptor 3, [Score=105, Expect=1e-22]; ENSMUSG00000023473, Celsr3, cadherin, EGF LAG seven-pass G-type receptor 3, [Score=105, Expect=1e-22]} {Dmel: FBgn0015609, CadN, Cadherin-N, [Score=246, Expect=2e-67]} {Celegans: WBGene00001980, hmr-1, Cadherin-related hmr-1, [Score=94.4, Expect=2e-19]} {Smed: dd_Smed_v6_9254_0_1, dd_Smed_v6_9254_0_1, [RH, Score=72.4, Expect=6e-13]} {RNA1509_55246} {RNA1310_146.1} {RNA815_6414} |
76. | MligTC455_00141 | 3 | 0.05 | Mlig455_021743 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_021743 {REF} {Length: 493} {NoTransDecoderORF} | |
77. | MligTC455_08510 | 2 | 0.05 | Mlig455_015135 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_015135 {REF} {Length: 663} {NoTransDecoderORF} {RNA1310_38859} | |
78. | MligTC455_37796 | 8 | 0.16 | Mlig455_067876 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_067876 {REF} {Length: 2915} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=135.9]} {Smed: dd_Smed_v6_15195_0_1, dd_Smed_v6_15195_0_1, [Score=223, Expect=2e-65]} {RNA1310_29050} {RNA815_45392} | |
79. | MligTC455_00643 | 5 | 0.1 | Mlig455_031262 | Neo: - Age: - |
0.999 | - | - | - | - | 0.999 | - | Mlig455_031262 {REF} {Length: 898} {RNA1310_127036} | |
80. | MligTC455_01034 | 3 | 0.06 | Mlig455_059840 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_059840 {REF} {Length: 140} {NoTransDecoderORF} | |
81. | MligTC455_11540 | 6 | 0.12 | Mlig455_034390 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_034390 {REF} {Length: 366} {NoTransDecoderORF} {RNA1310_116105} | |
82. | MligTC455_11925 | 3 | 0.05 | Mlig455_019159, Mlig455_019160, Mlig455_038657 | Neo: - Age: - |
ANKFN1 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_019159 {REF} {Length: 710} {Smed: dd_Smed_v6_6406_0_1, dd_Smed_v6_6406_0_1, [Score=53.9, Expect=3e-08]} Mlig455_019160 {REF} {Length: 3099} {Human: ENSG00000153930, ANKFN1, ankyrin repeat and fibronectin type III domain containing 1, [Score=185, Expect=1e-47]} {Mouse: ENSMUSG00000047773, Ankfn1, ankyrin-repeat and fibronectin type III domain containing 1, [Score=171, Expect=2e-43]} {Dmel: FBgn0266418, wake, wide awake, [Score=168, Expect=2e-42]} {Celegans: WBGene00019935, R07E4.1, [Score=96.3, Expect=4e-20]} {Smed: dd_Smed_v6_6406_0_1, dd_Smed_v6_6406_0_1, [Score=205, Expect=1e-54]} {RNA1310_97649} Mlig455_038657 {REF} {Length: 4140} {Human: ENSG00000153930, ANKFN1, ankyrin repeat and fibronectin type III domain containing 1, [RH, Score=216, Expect=8e-57]} {Mouse: ENSMUSG00000047773, Ankfn1, ankyrin-repeat and fibronectin type III domain containing 1, [RH, Score=202, Expect=1e-52]} {Dmel: FBgn0266418, wake, wide awake, [RH, Score=205, Expect=2e-53]} {Celegans: WBGene00019935, R07E4.1, [Score=131, Expect=7e-31]} {Smed: dd_Smed_v6_6406_0_1, dd_Smed_v6_6406_0_1, [RH, Score=243, Expect=4e-66]} {RNA1310_97649} |
83. | MligTC455_13547 | 51 | 1.05 | Mlig455_053120 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_053120 {REF} {Length: 2475} {TRANSSPLICED} {Pfam: Glycine rich protein [PF12810.9, score=28.0]} {RNA1509_53418} {RNA1310_65225} {RNA815_38510} | |
84. | MligTC455_13649 | 22 | 0.47 | Mlig455_026598 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_026598 {REF} {Length: 488} {NoTransDecoderORF} {RNA1310_112682} {RNA815_48653} | |
85. | MligTC455_16204 | 11 | 0.24 | Mlig455_062547 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_062547 {REF} {Length: 1752} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=166.5]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=69.7, Expect=2e-12]} {Smed: dd_Smed_v6_22997_0_1, dd_Smed_v6_22997_0_1, [Score=63.5, Expect=2e-10]} | |
86. | MligTC455_32079 | 6 | 0.13 | Mlig455_060911 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_060911 {REF} {Length: 1680} {Pfam: Major surface glycoprotein [PF02349.17, score=25.5]} {RNA1509_49032} {RNA1310_76952} {RNA815_36697} | |
87. | MligTC455_33531 | 3 | 0.06 | Mlig455_055598, Mlig455_055628 | Neo: - Age: - |
TRIM6 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_055598 {REF} {Length: 2898} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=44.1]; RING-type zinc-finger [PF13445.8, score=32.2]; zinc finger of C3HC4-type, RING [PF15227.8, score=26.5]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=24.4]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=23.9]; zinc-RING finger domain [PF14634.8, score=21.5]; Zinc-finger of the MIZ type in Nse subunit [PF11789.10, score=19.0]} {Human: ENSG00000121236, TRIM6, tripartite motif containing 6, [RH, Score=53.5, Expect=1e-06]; ENSG00000162722, TRIM58, tripartite motif containing 58, [RH, Score=53.1, Expect=2e-06]} {Mouse: ENSMUSG00000072244, Trim6, tripartite motif-containing 6, [RH, Score=53.5, Expect=7e-08]} {Dmel: FBgn0265356, tn, thin, [Score=54.3, Expect=4e-07]} {Celegans: WBGene00003597, nhl-1, RING finger protein nhl-1, [Score=49.3, Expect=1e-05]} {RNA1509_12061} {RNA1310_7680, RNA1509_12061} {RNA1509_12061, RNA815_14629} Mlig455_055628 {REF} {Length: 2803} {TRANSSPLICED} {Pfam: NHL repeat [PF01436.23, score=44.1]; RING-type zinc-finger [PF13445.8, score=32.2]; zinc finger of C3HC4-type, RING [PF15227.8, score=26.5]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=24.4]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=23.9]; zinc-RING finger domain [PF14634.8, score=21.5]; Zinc-finger of the MIZ type in Nse subunit [PF11789.10, score=19.0]} {Human: ENSG00000121236, TRIM6, tripartite motif containing 6, [RH, Score=53.5, Expect=1e-06]; ENSG00000162722, TRIM58, tripartite motif containing 58, [RH, Score=53.1, Expect=2e-06]} {Mouse: ENSMUSG00000072244, Trim6, tripartite motif-containing 6, [RH, Score=53.5, Expect=7e-08]} {Dmel: FBgn0265356, tn, thin, [Score=54.3, Expect=4e-07]} {Celegans: WBGene00003597, nhl-1, RING finger protein nhl-1, [Score=49.3, Expect=1e-05]} {RNA1509_12061} {RNA1310_7680} {RNA815_14629} |
88. | MligTC455_57514 | 5 | 0.1 | Mlig455_047358 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_047358 {REF} {Length: 108} {NoTransDecoderORF} {RNA1310_106874} | |
89. | MligTC455_24523 | 144 | 2.99 | Mlig455_010636, Mlig455_010724 | Neo: - Age: - Region-enriched R2: 9.355/0.00000 |
RGS6 | 0.997 | 0.997 | - | - | - | - | - | Mlig455_010636 {REF} {Length: 2512} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=118.4]; Regulator of G protein signaling domain [PF00615.21, score=116.4]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=31.3]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=301, Expect=3e-95]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=299, Expect=2e-94]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=290, Expect=6e-91]} {Dmel: FBgn0259927, CG42450, [RH, Score=327, Expect=2e-98]} {Celegans: WBGene00001145, eat-16, [Score=217, Expect=1e-63]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=384, Expect=1e-127]} {RNA1509_59108} {RNA1310_13711, RNA1509_59108} {RNA1509_59108, RNA815_9935} Mlig455_010724 {REF} {Length: 2512} {Pfam: Regulator of G-protein signalling DHEX domain [PF18148.3, score=118.4]; Regulator of G protein signaling domain [PF00615.21, score=113.1]; Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP) [PF00610.23, score=31.3]} {Human: ENSG00000182732, RGS6, regulator of G protein signaling 6, [Score=299, Expect=2e-94]} {Mouse: ENSMUSG00000021219, Rgs6, regulator of G-protein signaling 6, [Score=297, Expect=2e-93]; ENSMUSG00000026527, Rgs7, regulator of G protein signaling 7, [Score=287, Expect=4e-90]} {Dmel: FBgn0259927, CG42450, [RH, Score=324, Expect=1e-97]} {Celegans: WBGene00001145, eat-16, [Score=214, Expect=8e-63]} {Smed: dd_Smed_v6_5311_0_1, dd_Smed_v6_5311_0_1, [RH, Score=382, Expect=8e-127]} {RNA1509_59108} {RNA1310_13711} {RNA815_9935} |
90. | MligTC455_52730 | 38 | 0.79 | Mlig455_070287 | Neo: - Age: - |
PRKCB | 0.997 | - | - | 0.997 | - | - | - | Mlig455_070287 {REF} {Length: 3656} {Pfam: Protein kinase domain [PF00069.27, score=223.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=132.1]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=116.7]; C2 domain [PF00168.32, score=103.6]; Protein kinase C terminal domain [PF00433.26, score=33.3]; C1 domain [PF03107.18, score=21.6]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=993, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=969, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=992, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=972, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=967, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=952, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1057, Expect=0.0]} {RNA1509_44778} {RNA1310_40887} {RNA815_2012.1} |
91. | MligTC455_53937 | 44 | 0.92 | Mlig455_021975, Mlig455_022028 | Neo: - Age: - |
0.997 | - | - | 0.997 | - | - | - | Mlig455_021975 {REF} {Length: 631} {NoTransDecoderORF} {RNA1310_130902} Mlig455_022028 {REF} {Length: 192} {NoTransDecoderORF} {RNA1310_130902} |
|
92. | MligTC455_12116 | 106 | 2.2 | Mlig455_004661, Mlig455_004728 | Neo: - Age: Up-Up-Down |
0.996 | - | - | 0.996 | - | - | - | Mlig455_004661 {REF} {Length: 3441} {RNA1509_48407} {RNA1310_2938.1} {RNA815_14343.2} Mlig455_004728 {REF} {Length: 2670} {RNA1509_48407} {RNA1310_45267.1, RNA1509_48407} {RNA1509_48407, RNA815_58661} |
|
93. | MligTC455_29030 | 141 | 2.93 | Mlig455_061986 | Neo: - Age: logFC(26M/2M)=-0.349 Region-enriched R2: 5.117/0.03372 |
FZD5 | 0.996 | 0.996 | - | - | - | - | - | Mlig455_061986 {REF} {Length: 3701} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=386.1]; Fz domain [PF01392.24, score=95.9]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=586, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=545, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=388, Expect=7e-127]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [RH, Score=556, Expect=0.0]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
94. | MligTC455_46052 | 159 | 3.31 | Mlig455_020714 | Neo: - Age: - Region-enriched R2: 2.603/0.01508 |
TRAF5 | 0.996 | 0.996 | - | - | - | - | - | Mlig455_020714 {REF} {Length: 919} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=90.5, Expect=3e-20]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=88.2, Expect=1e-20]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=73.6, Expect=8e-15]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=98.6, Expect=1e-23]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=135, Expect=1e-36]} {RNA1310_36792.1} {RNA815_40908} |
95. | MligTC455_37198 | 5 | 0.1 | Mlig455_030331 | Neo: - Age: Up-Down-Up |
SLC6A9 | 0.995 | - | - | - | - | 0.995 | - | Mlig455_030331 {REF} {Length: 5536} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=102.8]} {Human: ENSG00000196517, SLC6A9, solute carrier family 6 member 9, [Score=105, Expect=3e-22]} {Mouse: ENSMUSG00000028542, Slc6a9, solute carrier family 6 (neurotransmitter transporter, glycine), member 9, [Score=104, Expect=2e-22]} {Dmel: FBgn0034136, DAT, Dopamine transporter, [Score=103, Expect=3e-22]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=189, Expect=5e-50]} {RNA1509_45036} {RNA1310_7320} {RNA815_2265} |
96. | MligTC455_43377 | 165 | 3.44 | Mlig455_010858 | Neo: - Age: - |
ECI1 | 0.994 | - | - | 0.994 | - | - | - | Mlig455_010858 {REF} {Length: 1478} {TRANSSPLICED} {Pfam: Enoyl-CoA hydratase/isomerase [PF00378.22, score=129.1]; Enoyl-CoA hydratase/isomerase [PF16113.7, score=44.2]} {Human: ENSG00000167969, ECI1, enoyl-CoA delta isomerase 1, [RH, Score=156, Expect=2e-45]} {Mouse: ENSMUSG00000024132, Eci1, enoyl-Coenzyme A delta isomerase 1, [RH, Score=171, Expect=1e-51]} {Dmel: FBgn0032160, CG4598, [RH, Score=165, Expect=2e-49]} {RNA1509_59982} {RNA1310_26151} {RNA815_13315} |
97. | MligTC455_49915 | 91 | 1.9 | Mlig455_037157, Mlig455_038485, Mlig455_038494, Mlig455_052306 | Neo: - Age: - Regeneration-upregulated R6: 6.503 Regeneration-enriched R6: 6.503 |
0.994 | - | - | - | - | 0.994 | - | Mlig455_037157 {REF} {Length: 854} {TRANSSPLICED} {Pfam: F5/8 type C domain [PF00754.27, score=19.5]} {RNA1310_67463} {RNA815_34968} Mlig455_038485 {REF} {Length: 849} {TRANSSPLICED} {Pfam: F5/8 type C domain [PF00754.27, score=19.5]} {RNA1310_67463} {RNA815_34968} Mlig455_038494 {REF} {Length: 860} {TRANSSPLICED} {Pfam: F5/8 type C domain [PF00754.27, score=26.7]} {RNA1310_67463} {RNA815_34968} Mlig455_052306 {REF} {Length: 854} {TRANSSPLICED} {Pfam: F5/8 type C domain [PF00754.27, score=19.5]} {RNA1310_67463} {RNA815_34968} |
|
98. | MligTC455_53176 | 54 | 1.13 | Mlig455_051303 | Neo: - Age: - Region-enriched R2: 4.924/0.00950 |
0.994 | 0.994 | - | - | - | - | - | Mlig455_051303 {REF} {Length: 1642} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=25.6]} {Dmel: FBgn0083971, CG34135, [RH, Score=61.6, Expect=7e-11]} {RNA1310_56013} | |
99. | MligTC455_54337 | 46 | 0.96 | Mlig455_000362 | Neo: - |
PKDREJ | 0.994 | 0.994 | - | - | - | - | - | Mlig455_000362 {REF} {Length: 11405} {Pfam: Polycystin cation channel [PF08016.14, score=291.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; Ion transport protein [PF00520.33, score=42.2]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.7]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=274, Expect=2e-73]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=306, Expect=2e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=152, Expect=6e-37]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=291, Expect=4e-79]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=1425, Expect=0.0]} {RNA1509_16432} {RNA1310_1236, RNA1509_16432} {RNA1509_16432, RNA815_2411} |
100. | MligTC455_12982 | 36 | 0.75 | Mlig455_006422 | Neo: - Age: - |
0.993 | - | - | - | - | 0.993 | - | Mlig455_006422 {REF} {Length: 2640} {RNA1509_54360} {RNA1310_27673} {RNA815_16736} |